University of Dundee

MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) Prize Studentships

  • MRC logo

We are currently accepting applications for our 2021 programme. Please send a CV with contact details of three referees to, including a cover letter explaining your interest in our work. Please also indicate which group(s) you are most interested in, and whether you prefer rotations or would like to join one lab directly.

Deciphering how disruptions in phosphorylation and ubiquitin networks lead to disease will reveal novel drug targets and improved strategies to treat these maladies in the future. Recent research has highlighted an exquisite interplay between phosphorylation and ubiquitin pathways that regulate many physiological systems. This includes pathways of relevance to understanding innate immunity, Parkinson's disease and cancer. Central questions being addressed by the research groups in the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) include understanding how ubiquitin and phosphorylation pathways are organised, characterising the interplay between these pathways, determining how they recognise and respond to signals, and uncovering how disruption of these networks causes disease.

The MRC Protein Phosphorylation and Ubiquitylation Unit (MRCPPU) is based in the School of Life Sciences. The MRC PPU PhD programme provides research training to candidates with an outstanding academic record and strong interest in carrying out research on the roles of protein phosphorylation in cell regulation and human disease. Although the Unit operates its own PhD programme its students are registered with the University of Dundee.  The positions offered are 4 yr studentship, which involves rotations in two MRC PPU labs in the first year. Details can be found at the MRC Prize Studentship website, 

The key elements of the programme consist of:

  • PhD projects in laboratories run by internationally renowned scientists
  • Structured training and mentoring programme
  • Competitive stipend of £20,000 per annum, tuition fees, relocation allowance and £2000 towards attendance at conferences and training courses.
  • Interaction with internationally renowned pharmaceutical companies

Further information

For further information and how to apply for this programme please see the our website,